<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tian X</submitter><funding>NCI NIH HHS</funding><pagination>8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6423228</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3</volume><pubmed_abstract>The development of genetic engineering in the 1970s marked a new frontier in genome-editing technology. Gene-editing technologies have provided a plethora of benefits to the life sciences. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/ Cas9) system is a versatile technology that provides the ability to add or remove DNA in the genome in a sequence-specific manner. Serious efforts are underway to improve the efficiency of CRISPR/Cas9 targeting and thus reduce off-target effects. Currently, various applications of CRISPR/Cas9 are used in cancer biology and oncology to perform robust site-specific gene editing, thereby becoming more useful for biological and clinical applications. Many variants and applications of CRISPR/Cas9 are being rapid</pubmed_abstract><journal>NPJ precision oncology</journal><pubmed_title>CRISPR/Cas9 - An evolving biological tool kit for cancer biology and oncology.</pubmed_title><pmcid>PMC6423228</pmcid><funding_grant_id>R01 CA166011</funding_grant_id><funding_grant_id>R01 CA187027</funding_grant_id><funding_grant_id>R01 CA196639</funding_grant_id><pubmed_authors>Gu T</pubmed_authors><pubmed_authors>Lee MH</pubmed_authors><pubmed_authors>Tian X</pubmed_authors><pubmed_authors>Patel S</pubmed_authors><pubmed_authors>Dong Z</pubmed_authors><pubmed_authors>Bode AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>CRISPR/Cas9 - An evolving biological tool kit for cancer biology and oncology.</name><description>The development of genetic engineering in the 1970s marked a new frontier in genome-editing technology. Gene-editing technologies have provided a plethora of benefits to the life sciences. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/ Cas9) system is a versatile technology that provides the ability to add or remove DNA in the genome in a sequence-specific manner. Serious efforts are underway to improve the efficiency of CRISPR/Cas9 targeting and thus reduce off-target effects. Currently, various applications of CRISPR/Cas9 are used in cancer biology and oncology to perform robust site-specific gene editing, thereby becoming more useful for biological and clinical applications. Many variants and applications of CRISPR/Cas9 are being rapid</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-05-29T20:27:18.943Z</modification><creation>2025-05-29T20:27:18.943Z</creation></dates><accession>S-EPMC6423228</accession><cross_references><pubmed>30911676</pubmed><doi>10.1038/s41698-019-0080-7</doi></cross_references></HashMap>